SAN FERNANDO, Calif. -- Precision Dynamics Corporation (PDC), a global leader in automatic wristband identification, has signed a reseller agreement with Hewlett-Packard Taiwan, Ltd., intended to accelerate the adoption of RFID (radio frequency identification) solutions in the Taiwan healthcare market.
Under the agreement and effective immediately, HP Taiwan is granted an exclusive license to offer PDC RFID Wristbands, including Smart Band®, SuperBand®, ScanBand®, CompuBand®, and Smart AgeBand, as part of its healthcare IT offering to hospitals in Taiwan. PDC will also provide sales and technical support. The RFID solution will initially be targeted for use in operating rooms of hospitals that are ready to implement the technology to help prevent medical errors.
"Our collaboration with HP Taiwan is an important step for PDC as it significantly extends our ability to deliver solutions to customers in Asia, says Gary Hutchinson, PDC president/CEO. We are pleased that HP selected PDC technology and look forward to building a lasting and successful partnership.
"As a result of our alliance with PDC, we are creating robust RFID solutions that will help prevent medical errors in hospitals, says Mingpey Chou, HP Taiwan RFID initiative lead. We look forward to working with PDC to make this initiative a great success.
PDC and HP Taiwan have begun an RFID implementation at Keelung Chang Gung Memorial Hospital in Taiwan. During the initial phase of the implementation, PDC Smart Band RFID Wristbands will be used in the hospitals operating room to identify the right patient, right surgical site, right nurse, right blood, and right doctor. This additional safety check is expected to help reduce human errors and enhance the safety of patients. This is the first RFID implementation to transpire from the reseller agreement.
Source: Precision Dynamics
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.